切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2021, Vol. 07 ›› Issue (02): 97 -102. doi: 10.3877/cma.j.issn.2096-1537.2021.02.001

专家论坛    下一篇

新型冠状病毒肺炎相关性急性胰腺炎:证据,挑战与思考
黄东亚 1, 苗毅 1, 蒋奎荣 1, 彭云鹏 1, 李强 1 , ( )   
  1. 1. 210029 南京医科大学第一附属医院胰腺中心
  • 收稿日期:2021-03-14 出版日期:2021-05-28
  • 通信作者: 李强
  • 基金资助:
    国家自然科学基金资助项目(81672449); 强卫工程医学杰出人才项目(JCRCA2016009); 江苏省重大疾病生物资源样本库项目(BM2015004); 江苏省高校优势学科和创新团队项目(JX10231802)

Acute pancreatitis related to COVID-19: evidence, challenge and reflection

Dongya Huang 1, Yi Miao 1, Kuirong Jiang 1, Yunpeng Peng 1, Qiang Li 1( )   

  1. 1. Department of Pancreas Center, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China
  • Received:2021-03-14 Published:2021-05-28
  • Corresponding author: Qiang Li

由新型冠状病毒(SARS-CoV-2)感染引起的新型冠状病毒肺炎(COVID-19)自2019年12月发病以来,现已全球大流行。COVID-19除影响呼吸系统外,还可造成全身多系统、多脏器的损害。目前关于COVID-19累及胰腺的证据十分有限,COVID-19患者中急性胰腺炎(AP)的发病率存在不确定性,其临床特征和发病机制也存在诸多疑问。在全球COVID-19流行仍未得到完全控制的背景下,由于目前对COVID-19与AP之间相互作用知之甚少,我们必须警惕他们之间可能存在的联系。临床上诸多治疗程序需要合理化,应采取有效的防护措施,在科学诊治患者的同时有效避免医护人员SARS-CoV-2感染。

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a world-wide pandemic since its onset in December of 2019. Not only capable of cause pneumonia, COVID-19 may also damage other organs. The data about pancreatic indueced by COVID-19 was limited. The incidence, clinical course, pathogenesis and outcomes of acute pancreatitis in these patients remain uncertain. The interaction between SARS-CoV-2 and pancreas are also limited. Therefore, it is imperative for us to keep in mind the possible association between COVID-19 and acute pancreatitis. Hence, rational therapeutic procedures should performed during this pandemic. Effective protective measures should be taken to prevent SARS-CoV-2 infection among health care workers when take care these patients.

1
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China [J]. N Engl J Med, 2020, 382(18): 1708-1720.
2
Xiao F, Tang M, Zheng X, et al. Evidence for gastrointestinal infection of SARS-CoV-2 [J]. Gastroenterology, 2020, 158(6): 1831-1833.
3
Aroniadis OC, Dimaio CJ, Dixon RE, et al. Current knowledge and research priorities in the digestive manifestations of COVID-19 [J]. Clin Gastroenterol Hepatol, 2020, 18(8): 1682-1684.
4
O'Brien CM, Jung K, Dang W, et al. Collateral damage: the impact of the COVID-19 pandemic on acute abdominal emergency presentations [J]. J Am Coll Radiol, 2020, 17(11): 1443-1449.
5
Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis [J]. Lancet Gastroenterol Hepatol, 2020, 5(7): 667-678.
6
Wang F, Wang H, Fan J, et al. Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia [J]. Gastroenterology, 2020, 159(1): 367-370.
7
Liu F, Long X, Zhang B, et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection [J]. Clin Gastroenterol Hepatol, 2020, 18(9): 2128-2130.
8
McNabb-Baltar J, Jin DX, Grover AS, et al. Lipase elevation in patients with COVID-19 [J]. Am J Gastroenterol, 2020, 115(8): 1286-1288.
9
Bruno G, Fabrizio C, Santoro CR, et al. Pancreatic injury in the course of coronavirus disease 2019: a not-so-rare occurrence [J]. J Med Virol, 2021, 93(1): 74-75.
10
Barlass U, Wiliams B, Dhana K, et al. Marked elevation of lipase in COVID-19 disease: a cohort study [J]. Clin Transl Gastroenterol, 2020, 11(7): e215.
11
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus [J]. Gut, 2013, 62(1): 102-111.
12
Stephens JR, Wong J, Broomhead R, et al. Raised serum amylase in patients with COVID-19 may not be associated with pancreatitis [J]. Br J Surg, 2021, 108(4):e152-e153.
13
Wang K, Luo J, Tan F, et al. Acute pancreatitis as the initial manifestation in 2 cases of COVID-19 in Wuhan, China [J]. Open Forum Infect Dis, 2020, 7(9): a324.
14
Alloway BC, Yaeger SK, Mazzaccaro RJ, et al. Suspected case of COVID-19-associated pancreatitis in a child [J]. Radiol Case Rep, 2020, 15(8): 1309-1312.
15
Miao Y, Lidove O, Mauhin W. First case of acute pancreatitis related to SARS-CoV-2 infection [J]. Br J Surg, 2020, 107(8): e270.
16
Anand ER, Major C, Pickering O, et al. Acute pancreatitis in a COVID-19 patient [J]. Br J Surg, 2020, 107(7): e182.
17
Kumaran NK, Karmakar BK, Taylor OM. Coronavirus disease-19 (COVID-19) associated with acute necrotising pancreatitis (ANP) [J]. BMJ Case Rep, 2020, 13(9): e237903.
18
Elhence A, Mahapatra SJ, Vajpai T, et al. Acute pancreatitis and nosocomial COVID-19: cause specific host responses may determine lung injury [J]. Pancreatology, 2020, 20(7): 1258-1261.
19
Hadi A, Werge M, Kristiansen KT, et al. Coronavirus disease-19 (COVID-19) associated with severe acute pancreatitis: case report on three family members [J]. Pancreatology, 2020, 20(4): 665-667.
20
Aloysius MM, Thatti A, Gupta A, et al. COVID-19 presenting as acute pancreatitis [J]. Pancreatology, 2020, 20(5): 1026-1027.
21
Schepis T, Larghi A, Papa A, et al. SARS-CoV2 RNA detection in a pancreatic pseudocyst sample [J]. Pancreatology, 2020, 20(5): 1011-1012.
22
姚小红, 李廷源, 何志承, 等. 新型冠状病毒肺炎(COVID-19)三例遗体多部位穿刺组织病理学研究 [J]. 中华病理学杂志, 2020, 49(5): 411-417.
23
Lax SF, Skok K, Zechner P, et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome : results from a prospective, single-center, clinicopathologic case series [J]. Ann Intern Med, 2020, 173(5): 350-361.
24
Hanley B, Naresh KN, Roufosse C, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study [J]. Lancet Microbe, 2020, 1(6): e245-e253.
25
Gubatan J, Levitte S, Patel A, et al. Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California [J]. Gut, 2021, 70(2): 440-441.
26
Bonney GK, Gao Y, Chew CA, et al. SARS-COV-2 associated acute pancreatitis: cause, consequence or epiphenomenon? [J]. Pancreatology, 2020, 20(5): 1017-1018.
27
Inamdar S, Benias PC, Liu Y, et al. Prevalence, risk factors, and outcomes of hospitalized patients with coronavirus disease 2019 presenting as acute pancreatitis [J]. Gastroenterology, 2020, 159(6): 2226-2228.
28
Dirweesh A, Li Y, Trikudanathan G, et al. Clinical outcomes of acute pancreatitis in patients with coronavirus disease 2019 [J]. Gastroenterology, 2020, 159(5): 1972-1974.
29
Pandanaboyana S, Moir J, Leeds JS, al et; COVID PAN collaborative group. SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study [J]. Gut, 2021, 70(6): 1061-1069.
30
Rawla P, Bandaru SS, Vellipuram AR. Review of infectious etiology of acute pancreatitis [J]. Gastroenterol Res, 2017, 10(3): 153-158.
31
Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor [J]. Cell, 2020, 181(2): 271-280.
32
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin [J]. Nature, 2020, 579(7798): 270-273.
33
Liu F, Long X, Zhang B, et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection [J]. Clin Gastroenterol Hepatol, 2020, 18(9): 2128-2130.
34
Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses [J]. Lancet, 2020, 395(10235): 1517-1520.
35
El-Kurdi B, Khatua B, Rood C, et al. Mortality from coronavirus disease 2019 increases with unsaturated fat and may be reduced by early calcium and albumin supplementation [J]. Gastroenterology, 2020, 159(3): 1015-1018.
36
Hegyi P, Szakacs Z, Sahin-Toth M. Lipotoxicity and cytokine storm in severe acute pancreatitis and COVID-19 [J]. Gastroenterology, 2020, 159(3): 824-827.
37
黄东亚, 苗毅, 蒋奎荣, 等. 重症患者伴高淀粉酶和/或高脂肪酶血症: 急性胰腺炎? [J/OL]. 中华重症医学电子杂志, 2017, 3(2): 138-142.
38
De-Madaria E, Siau K, Cardenas-Jaen K. Increased amylase and lipase in patients with COVID-19 pneumonia: don't blame the pancreas just yet! [J]. Gastroenterology, 2020, S0016-5085(20): 30561-30568.
39
Ashok A, Faghih M, Singh VK. Mild pancreatic enzyme elevations in COVID-19 pneumonia: synonymous with injury or noise? [J]. Gastroenterology, 2020, S0016-5085(20): 34778.
40
Mukherjee R, Smith A, Sutton R. Covid-19-related pancreatic injury [J]. Br J Surg, 2020, 107(7): e190.
41
Goyal H, Sachdeva S, Perisetti A, et al. Hyperlipasemia and potential pancreatic injury patterns in COVID-19: a marker of severity or innocent bystander? [J]. Gastroenterology, 2021, 160(3): 946-948.
42
Cerda-Contreras C, Nuzzolo-Shihadeh L, Camacho-Ortiz A, et al. Baricitinib as treatment for COVID-19: friend or foe of the pancreas? [J]. Clin Infect Dis, 2020: online ahead of print.
43
Khadka S, Williams K, Solanki S. "Remdesivir-Associated Pancreatitis" [J]. Am J Ther, 2021. Epub ahead of print.
44
Morrison AR, Johnson JM, Ramesh M, et al. Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab [J]. J Med Virol, 2020, 92(10): 1791-1792.
45
Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19 [J]. N Engl J Med, 2020, 382(19): 1787-1799.
46
Ng SC, Tilg H. COVID-19 and the gastrointestinal tract: more than meets the eye [J]. Gut, 2020, 69(6): 973-974.
47
Coccolini F, Tartaglia D, Puglisi A, et al. SARS-CoV-2 is present in peritoneal fluid in COVID-19 patients [J]. Ann Surg, 2020, 272(3): e240.
48
Stahel PF. How to risk-stratify elective surgery during the COVID-19 pandemic? [J]. Patient Saf Surg, 2020, 14: 8.
49
Zhou J, Li C, Liu X, et al. Infection of bat and human intestinal organoids by SARS-CoV-2 [J]. Nat Med, 2020, 26(7): 1077-1083.
[1] 骆永芳, 周丹, 曾嘉慧, 田文硕, 朱白沙, 包明稳, 冯文霞, 张宇, 冯程. 床旁肺部超声评估新型冠状病毒肺炎患者肺损伤的价值[J]. 中华医学超声杂志(电子版), 2022, 19(01): 42-46.
[2] 张易薇, 朱双双, 谢雨霁, 孙薇, 朱业, 吴纯, 李玉曼, 谢明星, 张丽. 组织运动二尖瓣环位移对新型冠状病毒肺炎患者预后的预测价值[J]. 中华医学超声杂志(电子版), 2021, 18(12): 1153-1157.
[3] 孟一星, 黄辉, 邓莉. 新型冠状病毒感染儿童皮肤损害[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(06): 374-378.
[4] 钱丹, 何佳霖, 林昊, 黄其密, 刘唯佳, 赵国策, 刘玺, 高梦圆, 潘鑫涛, 任成山. 老年糖尿病患者并发新型冠状病毒肺炎预后及其相关因素分析[J]. 中华肺部疾病杂志(电子版), 2022, 15(01): 33-37.
[5] 王雪飞, 任为正, 刘志伟, 赵永生, 徐菁, 寇佳琪, 何蕾. 经皮肾镜治疗重症急性胰腺炎院内死亡风险预测[J]. 中华腔镜外科杂志(电子版), 2021, 14(06): 326-331.
[6] 倪昊, 王发武, 李翔天, 马战胜. PSP下调miR-345-5p对雨蛙素诱导的AP腺泡细胞氧化应激和炎症因子表达[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(01): 8-13.
[7] 王仲, 丁仁彧, 马晓春. 临床医师对新型冠状病毒肺炎患者凝血相关事件认知的调查[J]. 中华重症医学电子杂志, 2022, 08(01): 49-54.
[8] 鲁卫华, 王涛, 秦雪梅, 徐前程, 姜小敢. 早期清醒俯卧位联合经鼻高流量氧疗治疗重型新型冠状病毒肺炎一例[J]. 中华重症医学电子杂志, 2022, 08(01): 85-89.
[9] 李保坤, 冯鋆, 周超熙, 张建锋, 王晓然, 马洪庆, 王光林, 牛文博, 于滨, 王贵英. 局部新型冠状病毒肺炎疫情暴发后结直肠癌临床诊疗模式转换研究[J]. 中华临床医师杂志(电子版), 2021, 15(11): 819-823.
[10] 席金川, 牛文博, 王飞飞, 刘友强, 李保坤, 王贵英. 新型冠状病毒肺炎疫情后医务工作者创伤后应激障碍探讨[J]. 中华临床医师杂志(电子版), 2021, 15(11): 824-827.
[11] 顾明兰, 马庆华, 陆敏. 新型冠状病毒肺炎疫情下基层预防接种门诊的实践[J]. 中华临床医师杂志(电子版), 2021, 15(08): 637-640.
[12] 王光林, 刘广杰, 胡旭华, 王飞飞, 张建锋, 樊少青, 孟泽松, 李保坤, 张娟, 王贵英. 新型冠状病毒肺炎疫情下结直肠癌患者的管理策略[J]. 中华临床医师杂志(电子版), 2021, 15(06): 401-406.
[13] 王晒晒, 马庆华, 周国锋, 孙国辉, 陈忠文, 王波, 张天阳. 苏州市相城区社区疫情防治医务工作者的焦虑感和孤独感现况调查[J]. 中华临床医师杂志(电子版), 2021, 15(05): 382-387.
[14] 刘颖, 沈君华, 张云, 王芳. "新型冠状病毒肺炎"疫情下某三级综合医院急诊患者就诊特点与急诊管理思考[J]. 中华卫生应急电子杂志, 2021, 07(06): 342-345.
[15] 周茜, 欧娜, 张福玲. 新型冠状病毒后疫情下医护患一体化微信视频探视在ICU中的应用研究[J]. 中华卫生应急电子杂志, 2021, 07(05): 272-276.
阅读次数
全文


摘要